Temasek aims to invest up to US$12bil in India as China weighs


File pic — Bloomberg

MUMBAI: Singapore state investor Temasek plans to invest up to $12 billion in India over three years in sectors such as financial services and healthcare, a top executive said on Monday, favouring the South Asian nation as it turns cautious on China.

India's economy is growing sharply and its stock markets are trading near record highs amid an IPO and dealmaking boom. India accounts for 7% of Temasek's global exposure which it wants to increase further, said Mohit Bhandari, the company's managing director for India investments.

Temasek had plans a year ago to invest around $9-10 billion in India over three years, but it is increasing that goal to $10-12 billion given the overall economic growth outlook, he added.

"We are bullish in India for the long term," Bhandari said in an interview at Temasek's Mumbai office.

"We are cognizant of the current economic and the geopolitical tensions that exist (in China) and to that extent we will align our portfolio accordingly," he added.

Temasek last week said that profits from investments in the United States and India were helping it cushion the impact of underperformance in China. Temasek also said that it is taking a cautious approach to China amid trade tensions.

About 22% of Temasek's investments are in the United States and 19% in China, and its exposure to the Americas surpassed China in the last financial year for the first time in a decade.

In India, Temasek deployed $3 billion in the fiscal year that ended March 31, its largest annual investment so far.

Bhandari also said that Temasek will look at hiring more investment professionals in India from the current 20 as its portfolio grows, but declined to share specifics.

Temasek's current India exposure includes investments in HDFC Bank, IPO-bound e-scooter maker Ola Electric and Manipal Hospitals.

In April 2023, Temasek spent $2 billion to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala.

Indian hospital chains and healthcare groups are seeing more and more interest from foreign investors as many expand into smaller cities where demand for private care is rising as public hospitals remain overburdened.

Temasek will continue to scout for more investment opportunities in the healthcare space as it believes the sector is a "multi-decade" growth story in India, Bhandari said. - Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Temasek , China , IPO , India

   

Next In Business News

Malaysia’s capital market hits RM4 trillion milestone, driven by strong domestic growth and IPO surge
TopVision makes ACE Market debut with 18% premium
China November industrial output rises 5.4%, above expectations
Foreign investors extend Bursa Malaysia sell-off with RM882.4mil outflow
Bitcoin surges above US$106,000 on strategic reserve hopes
Ringgit up marginally against US dollar in early trade
FBM KLCI inches up in early trade; TopVision shines in debut
Trading ideas: Axiata, Yinson, Datasonic, Exsim Hospitality, Lotte Chemical Titan, T7
Experts see big expansionary moves ahead by China’s government
MicroStrategy, Palantir added to Nasdaq 100, with Moderna facing an exit

Others Also Read